Results from EWTOPIA75 trial not enough to change practice, experts says
CHICAGO -- Elderly Japanese patients with elevated LDL cholesterol, but no history of coronary artery disease, who took ezetimibe (Zetia) saw a reduced risk of atherosclerotic cardiovascular events, researchers reported here.